02:17
ClinConvos Episode5
01:08
ClinConvos Episode4
02:08
ClinConvos Episode3
01:22
Our vaccine experience
02:07
ClinConvos Episode2
01:38
ClinConvos Episode1
01:26
Cultural Competence in Clinical Research
01:05
Holiday Wishes From Across the Globe
00:50
Meet Andy Fleming, Account Development Manager, Client Solutions
03:54
Participant Recruitment and Retention Can Require Agile Solutions
03:56
Project Profile: COVID-19 Study in Ghana
01:52
Following the Epidemiology in Infectious Disease Trials: A COVID-19 Case Study
01:33
Final Thoughts on PREVAIL Network Liberian Trip
02:10
COVID-19 Impact on Liberian Healthcare Systems
01:30
What’s Next for the PREVAIL Network?
03:27
Importance of Local Experts on the Ground
01:56
Action Items from PREVAIL Network Site Visit
01:04
Training, Knowledge and Skills for PREVAIL Network Site Staff
01:25
Takeaways From PREVAIL Network Trip
01:49
Purpose of Visit to PREVAIL network in Liberia
01:18
Holiday Message from Ted FitzGerald, FHI Clinical President and CEO
01:34
Mission-Driven
01:15
Long Standing Relationships
02:21
Building and Sustaining Research Capacity
54:40
Panel Discussion: The Impact of TB Preventive Treatment on Vaccine Development
00:34
George Belai on Successful Virtual Meetings
00:35
Michelle Atallah on FHI Clinical's Adaptability
00:33
Rob King discusses PREVAIL network in Liberia
01:00
Join us for World Vaccine Congress (WVC) Sept 28 - Oct 1, 2020
01:37
COVID-19 Announcement, Ted FitzGerald, CEO & President
X
About
We manage complex research in resource-limited settings around the world by leveraging our global expertise, responsive approaches and proven solutions. Our vision is a world where advances in vaccines and medicines help all people live longer, healthier lives.
Tags